NO20013978D0 - Dopamine D1 receptor agonist compounds - Google Patents
Dopamine D1 receptor agonist compoundsInfo
- Publication number
- NO20013978D0 NO20013978D0 NO20013978A NO20013978A NO20013978D0 NO 20013978 D0 NO20013978 D0 NO 20013978D0 NO 20013978 A NO20013978 A NO 20013978A NO 20013978 A NO20013978 A NO 20013978A NO 20013978 D0 NO20013978 D0 NO 20013978D0
- Authority
- NO
- Norway
- Prior art keywords
- dopamine
- receptor agonist
- agonist compounds
- compounds
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9903671.7A GB9903671D0 (en) | 1999-02-17 | 1999-02-17 | Dopamine D-1 receptor agonist compounds |
| PCT/GB2000/000570 WO2000049000A1 (en) | 1999-02-17 | 2000-02-17 | Dopamine d1 receptor agonist compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20013978L NO20013978L (en) | 2001-08-15 |
| NO20013978D0 true NO20013978D0 (en) | 2001-08-15 |
Family
ID=10847990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20013978A NO20013978D0 (en) | 1999-02-17 | 2001-08-15 | Dopamine D1 receptor agonist compounds |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1157009A1 (en) |
| JP (1) | JP2002537288A (en) |
| KR (1) | KR20010108228A (en) |
| CN (1) | CN1142916C (en) |
| AU (1) | AU767332B2 (en) |
| BR (1) | BR0008329A (en) |
| CA (1) | CA2363695A1 (en) |
| CZ (1) | CZ20012973A3 (en) |
| EA (1) | EA004745B1 (en) |
| GB (1) | GB9903671D0 (en) |
| HU (1) | HUP0200057A3 (en) |
| IL (1) | IL144810A0 (en) |
| MX (1) | MXPA01008294A (en) |
| NO (1) | NO20013978D0 (en) |
| PL (1) | PL349838A1 (en) |
| WO (1) | WO2000049000A1 (en) |
| ZA (1) | ZA200106478B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0130576D0 (en) * | 2001-12-20 | 2002-02-06 | Cenes Ltd | Dopamine D1 receptor agonist pro-drug compounds & derivatives |
| US7956050B2 (en) | 2005-07-15 | 2011-06-07 | Albany Molecular Research, Inc. | Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| WO2007019266A2 (en) * | 2005-08-03 | 2007-02-15 | Mineuet Therapeutics Ltd. | Killing human lymphoma and leukemia cancer cells and tcr-activated normal human cells by dopamine d1r agonists |
| CN101684096A (en) * | 2008-09-23 | 2010-03-31 | 中国科学院上海药物研究所 | Novel benzoazepine compound and preparation method and application thereof |
| CN102276531A (en) * | 2011-05-30 | 2011-12-14 | 扬子江药业集团广州海瑞药业有限公司 | Method for preparing fenoldopam mesylate |
| PT3013813T (en) | 2013-06-27 | 2019-06-14 | Pfizer | Heteroaromatic compounds and their use as dopamine d1 ligands |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1561305A (en) * | 1975-07-02 | 1980-02-20 | Smithkline Corp | Benzazepine derivatives and pharmeceutical compositions containing them |
| US4111957A (en) * | 1977-02-02 | 1978-09-05 | Smithkline Corporation | Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds |
| US4265889A (en) * | 1978-05-05 | 1981-05-05 | Smithkline Corporation | 6-Lower alkyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines |
| US4707483A (en) * | 1985-12-20 | 1987-11-17 | Smithkline Beckman Corporation | 1-phenyl-3-benzazepines and their use for treating gastrointestinal motility disorders |
| US4861771A (en) * | 1989-01-27 | 1989-08-29 | Smithkline Beckman Corporation | Carbamates of 6-chloro-7,8-dihydroxy-1-(4'-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine as prodrugs |
-
1999
- 1999-02-17 GB GBGB9903671.7A patent/GB9903671D0/en not_active Ceased
-
2000
- 2000-02-17 HU HU0200057A patent/HUP0200057A3/en unknown
- 2000-02-17 EA EA200100783A patent/EA004745B1/en not_active IP Right Cessation
- 2000-02-17 EP EP00903881A patent/EP1157009A1/en not_active Withdrawn
- 2000-02-17 JP JP2000599740A patent/JP2002537288A/en active Pending
- 2000-02-17 BR BR0008329-1A patent/BR0008329A/en not_active IP Right Cessation
- 2000-02-17 KR KR1020017010418A patent/KR20010108228A/en not_active Application Discontinuation
- 2000-02-17 CA CA002363695A patent/CA2363695A1/en not_active Abandoned
- 2000-02-17 CN CNB00803947XA patent/CN1142916C/en not_active Expired - Fee Related
- 2000-02-17 CZ CZ20012973A patent/CZ20012973A3/en unknown
- 2000-02-17 PL PL00349838A patent/PL349838A1/en not_active Application Discontinuation
- 2000-02-17 AU AU25632/00A patent/AU767332B2/en not_active Ceased
- 2000-02-17 WO PCT/GB2000/000570 patent/WO2000049000A1/en not_active Application Discontinuation
- 2000-02-17 IL IL14481000A patent/IL144810A0/en unknown
- 2000-02-17 MX MXPA01008294A patent/MXPA01008294A/en unknown
-
2001
- 2001-08-07 ZA ZA200106478A patent/ZA200106478B/en unknown
- 2001-08-15 NO NO20013978A patent/NO20013978D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1157009A1 (en) | 2001-11-28 |
| MXPA01008294A (en) | 2002-07-02 |
| NO20013978L (en) | 2001-08-15 |
| HUP0200057A2 (en) | 2002-08-28 |
| BR0008329A (en) | 2002-01-29 |
| AU767332B2 (en) | 2003-11-06 |
| AU2563200A (en) | 2000-09-04 |
| EA004745B1 (en) | 2004-08-26 |
| KR20010108228A (en) | 2001-12-07 |
| ZA200106478B (en) | 2002-02-07 |
| PL349838A1 (en) | 2002-09-23 |
| CZ20012973A3 (en) | 2002-01-16 |
| CN1341102A (en) | 2002-03-20 |
| EA200100783A1 (en) | 2002-02-28 |
| HUP0200057A3 (en) | 2004-03-29 |
| WO2000049000A1 (en) | 2000-08-24 |
| IL144810A0 (en) | 2002-06-30 |
| CN1142916C (en) | 2004-03-24 |
| JP2002537288A (en) | 2002-11-05 |
| GB9903671D0 (en) | 1999-04-14 |
| CA2363695A1 (en) | 2000-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1189916T3 (en) | N-pyrazole A 2A receptor agonists | |
| DK1446379T3 (en) | Arylanilin-beta2-adrenergic receptor agonists | |
| ATE366729T1 (en) | TRIAZOLE COMPOUNDS WITH DOPAMINE D3 RECEPTOR AFFINITY | |
| DE69903953D1 (en) | 2-SUBSTITUTED-1-PIPERIDYL-BENZIMIDAZOLE COMPOUNDS AS ORL1 RECEPTOR AGONISTS | |
| DE60132799D1 (en) | PEROXISOM PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS | |
| PT1192169E (en) | A2A RECEPTOR AGONIST C-PYRAZOLES | |
| PT1347760E (en) | PHARMACEUTICAL COMPOUNDS OF NMDA RECEPTOR AGONIST | |
| DE60018989D1 (en) | N-CARBAMOYLOXYALKYL SUBSTITUTED AZOLIUM COMPOUNDS | |
| NO20042737L (en) | Peroxisome proliferator activated receptor agonists | |
| NO20013997D0 (en) | Receptor | |
| NO20016077L (en) | Macrophage scavenger receptor antagonists | |
| NO20016053D0 (en) | IL-8 receptor antagonists | |
| MA26890A1 (en) | EESTROGEN AGONIST / ANTAGONIST METABOLITES | |
| DE60130000D1 (en) | TWITTER TACHYKININE RECEPTOR ANTAGONISTS | |
| NO20016052L (en) | IL-8 receptor antagonists | |
| DK1146874T3 (en) | Vitronectin receptor agonist | |
| NO20013978D0 (en) | Dopamine D1 receptor agonist compounds | |
| ATE352299T1 (en) | IL-8 RECEPTOR ANTAGONIST | |
| ATE264301T1 (en) | MUSCARINE ANTAGONISTS | |
| NO20015774D0 (en) | IL-8 receptor antagonists | |
| NO20021295D0 (en) | Nikotinsyreacetylcholin receptor | |
| GB0130576D0 (en) | Dopamine D1 receptor agonist pro-drug compounds & derivatives | |
| NO20016065D0 (en) | IL-8 receptor antagonists | |
| NO20016102L (en) | IL-8 receptor antagonists | |
| DK1207159T3 (en) | Heteroaromatic derivatives such as dopamine D4 receptor antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |